Headlines & Media Coverage
What the press is saying about ABILITY Neurotech and our work in brain-computer interfaces.
Recent Headlines & Media Mentions
Jul 27, 2026 Four Swiss medtechs mark commercial, regulatory and clinical milestones
Startupticker highlights ABILITY Neurotech among four Swiss medtech companies reaching major milestones, noting the Geneva-based startup completed its first-in-human BCI procedure at a Munich hospital, recording neural data from brain-tumor surgery patients.
Jul 27, 2026 Implantable Neural Interface Undergoes First Real-World Surgical Validation
HospiMedica covers ABILITY Neurotech's first-in-human evaluation of its fully implantable brain-computer interface at a Munich hospital, validating the platform's signal acquisition capabilities ahead of long-term implantation trials.
Jul 24, 2026 ABILITY Neurotech reaches first-in-human at TUM Munich
Inside BCI reports on ABILITY Neurotech's first-in-human recording of its fully implantable, batteryless brain-computer interface at TUM University Hospital, using a 128-channel ECoG array with novel infrared optical data transmission.
Jul 22, 2026 A Geneva BCI Company Records Its First Human Neural Data, and Europe Gets a Serious Entrant
Synopulse covers how ABILITY Neurotech recorded human neural data for the first time during tumour surgery in Munich, marking its first step toward a long-term implantable brain-computer interface and establishing Europe as a serious contender in BCI.
Jul 22, 2026 Science gains CE mark; Ability, Precision show BCI capabilities
BioWorld reports on key BCI milestones including ABILITY Neurotech's first-in-human implantation successfully recording neural signals, alongside Precision Neuroscience's real-time cursor control demonstration and Science Corp.'s CE mark for its retinal implant.
Jul 22, 2026 Science fiction realized: BCI tech is here
BioWorld's comprehensive feature explores how brain-computer interface technology is transforming from science fiction to clinical reality, with companies like ABILITY Neurotech advancing implantable BCIs that can restore communication and movement.
Jul 22, 2026 Ability Neurotech says its BCI system's electrodes and speed set it apart
An in-depth feature exploring how ABILITY Neurotech's high-density ECoG electrodes and 50 Mb/s optical data link differentiate its fully implantable BCI from competing approaches in the rapidly evolving brain-computer interface landscape.
Jul 22, 2026 Ability Neurotech announces first-in-human testing of novel BCI technology
NeuroNews International reports on ABILITY Neurotech's inaugural human procedure for its brain-computer interface technology at a Munich hospital, successfully capturing neural signals during surgery as the company advances toward long-term implantable BCIs.
Jul 22, 2026 ABILITY Neurotech Announces First-In-Human Testing for Novel BCI Technology
Biology Digital covers ABILITY Neurotech's first clinical trial of brain-computer interface technology at the Technical University of Munich, marking the company's transition into clinical development to restore communication for patients with severe neurological conditions.
Jul 21, 2026 Ability Neurotech Tests BCI Implant in First Human
Medical Design & Development covers ABILITY Neurotech's first-in-human test of its fully implantable brain-computer interface, highlighting the company's milestone procedure at the Technical University of Munich.
Jul 21, 2026 ABILITY Neurotech enters clinic in race to restore speech, movement via BCI
FirstWord HealthTech reports on ABILITY Neurotech's entry into the clinical stage with its first-in-human brain-computer interface procedure, as the company races to restore speech and movement for patients with severe neurological conditions.
Jul 21, 2026 ABILITY Neurotech Announces First-In-Human Testing for Novel Brain-Computer Interface Technology
The AI Journal covers ABILITY Neurotech's first-in-human brain-computer interface procedure at the Technical University of Munich, marking early feasibility testing of the company's fully implantable optical BCI system for restoring communication and movement.
Jul 21, 2026 ABILITY Neurotech Announces First-In-Human Testing for Novel Brain-Computer Interface Technology
Health Technology Net reports on ABILITY Neurotech's intra-operative study conducted with TU Munich Klinikum Rechts der Isar, marking the initial human application of ABILITY's brain-computer interface signal recording technology.
Jul 21, 2026 Ability Neurotech Moves Implantable, Batteryless BCI Into First-In-Human Trial
An in-depth look at ABILITY Neurotech's move into first-in-human trials with its fully implantable, battery-free brain-computer interface, featuring its unique optical data link technology.
Jul 21, 2026 Ability Neurotech looks to bring 'mature' implant to BCI market
Mass Device explores how ABILITY Neurotech is positioning its fully implantable BCI as a mature, clinical-grade platform ready for human use, differentiating from early-stage competitors.
Jul 21, 2026 ABILITY Neurotech Announces First-In-Human Testing for Novel Brain-Computer Interface Technology
ABILITY Neurotech announced today the first-in-human procedure for its BCI technology at TUM University Hospital Rechts der Isar, representing the first use of ABILITY's neural signal acquisition technology in a live surgical setting.
Jul 21, 2026 Ability Neurotech completes first-in-human test of brain-computer interface at TU Munich
ABILITY Neurotech has completed its first-in-human test of its brain-computer interface technology at the Technical University of Munich, capturing neural data in a live surgical setting.
Jul 21, 2026 ABILITY Neurotech Announces First-In-Human Testing for Novel Brain-Computer Interface Technology
ABILITY Neurotech announced today the first-in-human procedure for its BCI technology, conducted at TUM University Hospital Rechts der Isar, marking the first real-world validation of its neural signal acquisition.
Jul 21, 2026 Ability Neurotech completes first human BCI procedure
ABILITY Neurotech has completed its first-in-human procedure for its brain-computer interface technology at the Department for Neurosurgery at TUM University Hospital Rechts der Isar in Munich.
Jun 30, 2026 Ascending BCI systems deepen national security, ethical concerns
As brain-computer interface technology advances rapidly, new questions arise about dual-use implications, data sovereignty, and the ethical frameworks needed to govern neural devices.
Jun 23, 2026 Next wave of BCI firms builds on pioneers to tackle challenges
A new generation of brain-computer interface companies, including ABILITY Neurotech, is building on early pioneers to address the technical and regulatory hurdles that remain before BCIs can reach broad clinical use.
Jun 23, 2026 Neurotechnologies: Comment Genève tente d'exister face à la Silicon Valley
Geneva positions itself as a European hub for neurotechnology, with companies like ABILITY Neurotech emerging from the Wyss Center to compete on the global stage against Silicon Valley giants.
Jun 17, 2026 ABILITY's BCI Study Tests More Than Speech
NeuroFounders explores how ABILITY Neurotech's approved clinical study will test its ECoG-based brain-computer interface with optical data link beyond speech restoration, evaluating communication, computer control, and speech decoding in real-world home settings for ALS patients.
Jun 16, 2026 ABILITY Neurotech receives approval to start clinical trial
The Swiss-based brain-computer interface company has received regulatory approval in the Netherlands to begin its first chronic implantation study in ALS patients.
Jun 9, 2026 Optical brain implant moves into real-world use
ABILITY Neurotech's fully implantable BCI, featuring a 50 Mb/s transcutaneous optical data link, is moving from the lab into real-world clinical evaluation for restoring speech in paralysed patients.
May 28, 2026 ABILITY Neurotech: Unlocking the Potential of BCI
An in-depth feature exploring ABILITY Neurotech's approach to brain-computer interfaces, its optical-link technology, and the company's path toward clinical deployment for speech restoration.
May 28, 2026 Ability Neurotech can begin study of BCI in ALS patients
ABILITY Neurotech has secured IMDD approval to launch its first chronic implantation study of a fully implantable wireless brain-computer interface in ALS patients at UMC Utrecht.
May 28, 2026 ABILITY Neurotech gets approval to trial brain-computer interface in ALS patients
The clinical-stage BCI company has received ethics committee approval to trial its fully implantable device designed to restore communication for people living with ALS.
May 28, 2026 ABILITY Neurotech receives MREC approval for ALS BCI clinical trial
ABILITY Neurotech has received Medical Research Ethics Committee approval in the Netherlands for its first chronic implantation clinical trial of an ECoG-based brain-computer interface.
Media Inquiries
For press inquiries, interview requests, or media resources, please get in touch with our communications team.
Contact Us